Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MK 7762

Next Previous
Drug Profile

MK 7762

Alternative Names: MK-7762; TBD-09

Latest Information Update: 13 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Merck & Co
  • Developer Bill & Melinda Gates Medical Research Institute; Merck & Co
  • Class Amines; Antibacterials; Antituberculars; Carbamates; Chlorinated hydrocarbons; Cyclohexanes; Ethanolamines; Fluorobenzenes; Methyl ethers; Nitriles; Oxazolidinones; Pyrans; Pyridines; Thiamorpholines; Thiazoles
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Tuberculosis

Most Recent Events

  • 13 Aug 2025 Chemical structure information added.
  • 31 Jul 2025 Gates Medical Research Institute plans a phase I trial in healthy volunteers (PO) in September 2025 (NCT07094932)
  • 26 Mar 2024 Bill & Melinda Gates Medical Research Institute and Merck & Co completes a phase I trial in Tuberculosis (In volunteers) in USA (PO) (NCT05824091)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top